Henderson Group »

Dianthus Therapeutics shares owned by Henderson Group

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Henderson Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $11M 375k 30.00

More positions owned by Henderson Group

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Mastercard Incorporated Cl A (MA)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Abbvie (ABBV)
Lam Research Corporation (LRCX)
Booking Holdings (BKNG)
Progressive Corporation (PGR)
Oracle Corporation (ORCL)
Deere & Company (DE)

View all positions for Henderson Group

Top funds holding Dianthus Therapeutics

FMR
Bain Capital Life Sciences Investors
Fairmount Funds Management
Avidity Partners Management
RA Capital Management
VR Adviser
Octagon Capital Advisors
5AM Venture Management
Rtw Investments
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Henderson Group
Point72 Asset Management
Adage Capital Partners GP
Millennium Management

View all funds holding Dianthus Therapeutics